Document is current
Any future updates will be listed below
-
Authors
Li, Qian
Qin, Kun
Lei, Du
Li, Wenbin
Tallman, Maxwell J.
Patino, L. Rodrigo
Sweeney, John A.
Gong, Qiyong
Li, Fei
DelBello, Melissa P.
McNamara, Robert K.
-
Funding
Funding for this research was provided by:
National Key R&D Program (2022YFC2009900)
National Natural Science Foundation of China (82027808)
Sichuan Science and Technology Program (2024NSFSC0653)
R01 NIMH (097818)
R01 NIMH (097818)
- License Information
-
More Information
Article History
Received: 17 March 2025
Accepted: 9 November 2025
First Online: 18 November 2025
Declarations
:
: The protocol was approved by the Institutional Review Board of the University of Cincinnati, and this study was registered on clinicaltrials.gov (NCT02478788).
: M.P.D. receives research support from national institutes of health (NIH), PCORI, Alkermes, Intra-cellular Therapies Janssen, Johnson and Johnson, Sage, Shire, and Vanda. She is also a consultant, on the advisory board, or has received honoraria for speaking for American Academy of Child and Adolescent Psychiatry, Alkermes, Allergan, Johnson and Johnson, Lundbeck, Myriad, Sunovion and Sage. R.K.M. has received research support from Martek Biosciences Inc, Royal DSM Nutritional Products, LLC, Inflammation Research Foundation, Ortho-McNeil Janssen, AstraZeneca, Eli Lilly, NARSAD, and NIH, and previously served on the scientific advisory board of the Inflammation Research Foundation. The remaining authors do not have disclosures.
